Brivaracetam

Trade name

Briviact

Strength

10 mg/mL (volume: 5 mL)

IV administration

Give undiluted over at least 2 minutes, or dilute to a convenient volume and infuse over 15 minutes.

Other routes of administration

IM: Not recommended.

SC: Not recommended. 

Compatible IV fluids

Glucose 5%

Hartmann’s

Sodium chloride 0.9%

Additional information

Observe closely for anaphylactic reactions.

Patients may experience a bitter taste after administration.

Taper the dose slowly when discontinuing treatment; abrupt discontinuation may increase risk of seizures.

Discard any unused vial contents.